EUVIMEDEUVIMED entdecken
Crossref

Bayesian cell therapy process optimization

Evan Claes iD, Tommy Heck, Kathleen Coddens, Maarten Sonnaert, Jan Schrooten, Jan Verwaeren

Biotechnology and Bioengineering · 2024-05 · 121 (5) · 1569-1582

DOI: 10.1002/bit.28669 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology and Bioengineering, online erschienen am 19.02.2024. Verfasst von Evan Claes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Antleron, Leuven, Belgium. Hauptthemen laut MEDLINE: Research Design, Cell- and Tissue-Based Therapy. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Onderzoeksprogramma Artifciële Intelligentie (AI) Vlaanderen, VLAIO.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Optimizing complex bioprocesses poses a significant challenge in several fields, particularly in cell therapy manufacturing. The development of customized, closed, and automated processes is crucial for their industrial translation and for addressing large patient populations at a sustainable price. Limited understanding of the underlying biological mechanisms, coupled with highly resource‐intensive experimentation, are two contributing factors that make the development of these next‐generation processes challenging. Bayesian optimization (BO) is an iterative experimental design methodology that addresses these challenges, but has not been extensively tested in situations that require parallel experimentation with significant experimental variability. In this study, we present an evaluation of noisy, parallel BO for increasing noise levels and parallel batch sizes on two in silico bioprocesses, and compare it to the industry state‐of‐the‐art. As an in vitro showcase, we apply the method to the optimization of a monocyte purification unit operation. The in silico results show that BO significantly outperforms the state‐of‐the‐art, requiring approximately 50% fewer experiments on average. This study highlights the potential of noisy, parallel BO as valuable tool for cell therapy process development and optimization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Research DesignCell- and Tissue-Based TherapyHumansBayes Theorem

Stichwörter der Autor:innen

Bayesian optimizationcell therapycounterflow cell centrifugationprocess developmentprocess optimization

Autor:innen und Institutionen

  • Antleron, Leuven, Belgium.
  • Biovism, Department of Data Analysis and Mathematical Modelling, Faculty of Bioscience Engineering, Ghent University, Gent, Belgium.

ORCID-Profile: Evan Claes

Förderung

  • Onderzoeksprogramma Artifciële Intelligentie (AI) Vlaanderen
  • VLAIO

Zitieren

APA

Claes, E., Heck, T., Coddens, K., Sonnaert, M., Schrooten, J., & Verwaeren, J. (2024). Bayesian cell therapy process optimization. Biotechnology and Bioengineering, 121(5), 1569-1582. https://doi.org/10.1002/bit.28669

Vancouver

Claes E, Heck T, Coddens K, Sonnaert M, Schrooten J, Verwaeren J. Bayesian cell therapy process optimization. Biotechnology and Bioengineering. 2024;121(5):1569-1582. doi:10.1002/bit.28669

BibTeX
@article{Claes2024,
  author = {Claes, Evan and Heck, Tommy and Coddens, Kathleen and Sonnaert, Maarten and Schrooten, Jan and Verwaeren, Jan},
  title = {Bayesian cell therapy process optimization},
  journal = {Biotechnology and Bioengineering},
  year = {2024},
  volume = {121},
  number = {5},
  pages = {1569--1582},
  doi = {10.1002/bit.28669}
}
Kostenlos starten →